Is there an immune deficit in Whipple's disease?

Digestive Diseases and Sciences
W O Dobbins

Abstract

There is controversy as to the role of immune deficiency, if any, in Whipple's disease. This report summarizes published data in regard to immune function in this disease. Thirty-two publications during the past ten years offer varying amounts of immunological data in 61 patients--50 males, 6 females, and 5 patients in whom the sex was not reported. There is no evidence for humoral immune deficiency in these patients. Secretory immunoglobulins are within normal limits. Intestinal mucosal plasma cells are decreased before treatment, but are normal after treatment. There are no abnormal deposits of complement or immunoglobulins within the intestinal mucosa. There is no evidence for autoantibody production. These patients invariably have lymphocytopenia prior to treatment and have a decreased percentage of T cells both before and after treatment. There is decreased responsiveness of lymphocytes to the mitogens PHA and Con A, before and after treatment. The cutaneous response to antigens is clearly diminished before treatment, improves somewhat after treatment, but is still significantly less than that seen in normal controls. There may be an increased association with HLA B27, which suggests that an abnormality in the cellular imm...Continue Reading

References

Mar 20, 1975·The New England Journal of Medicine·F S Kantor
Jul 1, 1975·Acta Medica Scandinavica·L ElsborgN O Jacobsen
Aug 16, 1976·JAMA : the Journal of the American Medical Association·L C MaasE A Gelzayd
Sep 15, 1976·Acta Neuropathologica·S W SilbertS Horenstein
Jan 1, 1977·Digestion·G N TytgatP T Schellekens
Mar 1, 1977·Annals of Neurology·P F FinelliJ Copetto
Jun 1, 1977·Australian and New Zealand Journal of Medicine·R ClancyD Stevens
Apr 19, 1979·The New England Journal of Medicine·G E FeurleR Waldherr
May 31, 1979·Virchows Archiv. A, Pathological Anatomy and Histology·I BabarykaE Langer
Oct 1, 1979·European Journal of Clinical Investigation·G E FeurleV Lenhard
Nov 8, 1979·The New England Journal of Medicine·E L ReinherzS F Schlossman
Mar 1, 1979·The Journal of Experimental Medicine·C O ElsonW Strober
Jan 1, 1978·Immunological Reviews·E R Unanue
Oct 1, 1970·Acta Medica Scandinavica·E MyhreE Gjone
Mar 1, 1972·Archives of Internal Medicine·J R RodarteR S Fontana
Dec 1, 1973·The American Journal of Medicine·B M Pastor, R G Geerken
May 1, 1973·Postgraduate Medical Journal·M CochranM Peacock
Apr 27, 1968·Lancet·J D MaxwellW C Watson
Jan 1, 1969·Archives of Internal Medicine·D M SwitzG V Bogaty
Jan 1, 1969·Acta Neuropathologica·S S Schochet, P W Lampert

❮ Previous
Next ❯

Citations

Apr 1, 1997·Annals of Neurology·P J SchniderE Auff
Sep 1, 1984·Journal of Clinical Immunology·C A OttawayG A Levy
Mar 1, 1982·Digestive Diseases and Sciences·F Tavarela Veloso
Jun 15, 1988·Klinische Wochenschrift·A von Herbay, H F Otto
Mar 11, 2000·Neuromuscular Disorders : NMD·T R HelliwellK P Walsh
Jul 4, 2001·Clinical Microbiology Reviews·F Dutly, M Altwegg
Nov 7, 2000·Journal of Clinical Pathology·S A Misbah, N P Mapstone
Jan 28, 2003·Lancet·Thomas Marth, Didier Raoult
Feb 1, 1996·Baillière's Clinical Rheumatology·P D UtsingerJ H Utsinger
Jun 1, 1988·Scandinavian Journal of Gastroenterology·R BjerknesO D Laerum
Mar 15, 2018·ELife·Antoine GuérinJean-Laurent Casanova
Jun 26, 2007·Orvosi hetilap·Györgyi MuzesZsolt Tulassay
Jan 1, 1981·Critical Reviews in Clinical Laboratory Sciences·D F Keren
Jun 13, 2015·Revista brasileira de reumatologia·Guilherme Almeida Rosa da Silva, José Soares Pires Neto
Jan 1, 1987·Arthritis and Rheumatism·W O Dobbins
Jul 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Verena MoosThomas Schneider
Feb 15, 1985·Klinische Wochenschrift·K P StockJ F Riemann
May 20, 2020·International Journal of Peptide Research and Therapeutics·Amit Joshi, Vikas Kaushik
May 1, 1995·Journal of Clinical Microbiology·M MaiwaldA von Herbay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Clinical Investigation
G E FeurleV Lenhard
Australian and New Zealand Journal of Medicine
R ClancyD Stevens
The New England Journal of Medicine
G E FeurleR Waldherr
© 2021 Meta ULC. All rights reserved